808
Views
107
CrossRef citations to date
0
Altmetric
Research Paper

Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins

Pages 65-70 | Published online: 16 Jan 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yanis Boumber, Anas Younes & Guillermo Garcia-Manero. (2011) Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor. Expert Opinion on Investigational Drugs 20:6, pages 823-829.
Read now
Christophe Le Tourneau & Lillian L Siu. (2008) Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor. Expert Opinion on Investigational Drugs 17:8, pages 1247-1254.
Read now
James J. Pesavento, Hongbo Yang, Neil L. Kelleher & Craig A. Mizzen. (2008) Certain and Progressive Methylation of Histone H4 at Lysine 20 during the Cell Cycle. Molecular and Cellular Biology 28:1, pages 468-486.
Read now
Jan Reichelt, Stephanie C. Joachim, Norbert Pfeiffer & Franz H. Grus. (2008) Analysis of Autoantibodies Against Human Retinal Antigens in Sera of Patients with Glaucoma and Ocular Hypertension. Current Eye Research 33:3, pages 253-261.
Read now
Tatiana Nikitina, Xi Shi, Rajarshi P. Ghosh, Rachel A. Horowitz-Scherer, Jeffrey C. Hansen & Christopher L. Woodcock. (2007) Multiple Modes of Interaction between the Methylated DNA Binding Protein MeCP2 and Chromatin. Molecular and Cellular Biology 27:3, pages 864-877.
Read now

Articles from other publishers (101)

Alexis Germán Murillo Carrasco, Andreia Hanada Otake, Janaina Macedo-da-Silva, Veronica Feijoli Santiago, Giuseppe Palmisano, Luciana Nogueira de Sousa Andrade & Roger Chammas. (2023) Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. International Journal of Molecular Sciences 24:16, pages 13022.
Crossref
Alejandra Agredo & Andrea L. Kasinski. (2023) Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease. Frontiers in Genetics 14.
Crossref
Abeer A. Alsofyani & Yazan Samih Said. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1) 320 366 .
Yaguang Zhang, Qin Zhang, Yang Zhang & Junhong Han. (2023) The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. International Journal of Molecular Sciences 24:5, pages 4939.
Crossref
Yousef Rasmi, Johra Khan, Kakali Ghoshal & Behrokh Daei-Hasani. 2023. Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery. Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery 359 386 .
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang & Xianqun Fan. (2022) Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Communications 42:11, pages 1049-1082.
Crossref
Davide Gabellini & Simona Pedrotti. (2022) The SUV4-20H Histone Methyltransferases in Health and Disease. International Journal of Molecular Sciences 23:9, pages 4736.
Crossref
N. S. Kuzmina. (2022) Radiation-Induced DNA Methylation Disorders: In Vitro and In Vivo Studies. Biology Bulletin 48:11, pages 2015-2037.
Crossref
Megan H Trager, Bindeshwar Sah, Zhongming Chen & Liang Liu. (2021) Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase. Endocrinology 162:8.
Crossref
Adriana Z. Corvalan & Hilary A. Coller. (2021) Methylation of histone 4’s lysine 20: a critical analysis of the state of the field. Physiological Genomics 53:1, pages 22-32.
Crossref
Qian Zhou, Juan Guo, Wenjie Huang, Xiaosi Yu, Chen Xu & Xinghua Long. (2020) Linc‐ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR‐194‐3p targeting MECP2. Molecular Oncology 14:9, pages 2231-2250.
Crossref
Mauro Belli & Maria Antonella Tabocchini. (2020) Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection. International Journal of Molecular Sciences 21:17, pages 5993.
Crossref
Jessica S. Helm & Ruthann A. Rudel. (2020) Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Archives of Toxicology 94:5, pages 1511-1549.
Crossref
Wen Jin, Qian-Zhong Li, Yuan Liu & Yong-Chun Zuo. (2020) Effect of the key histone modifications on the expression of genes related to breast cancer. Genomics 112:1, pages 853-858.
Crossref
Yuan Cheng, Cai He, Manni Wang, Xuelei Ma, Fei Mo, Shengyong Yang, Junhong Han & Xiawei Wei. (2019) Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduction and Targeted Therapy 4:1.
Crossref
Veronika A. Myasoedova, Vasily Sukhorukov, Andrey V. Grechko, Dongwei Zhang, Elena Romanenko, Vawain Orekhov & Alexander N. Orekhov. (2019) Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy. Current Pharmaceutical Design 25:6, pages 635-641.
Crossref
Yinglu Li, Zhiming Li & Wei-Guo Zhu. (2019) Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics. Current Medicinal Chemistry 26:8, pages 1328-1350.
Crossref
Rochelle Wickramasekara & Holly Stessman. (2019) Histone 4 Lysine 20 Methylation: A Case for Neurodevelopmental Disease. Biology 8:1, pages 11.
Crossref
You Wu, Wanyue Shi, Tingting Tang, Yidong Wang, Xin Yin, Yanlin Chen, Yanfeng Zhang, Yun Xing, Yumeng Shen, Tiansong Xia, Changying Guo, Yi Pan & Liang Jin. (2019) miR-29a contributes to breast cancer cells epithelial–mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death & Disease 10:3.
Crossref
Aniket Kumar Bansal, Laishram Rajendrakumar Singh & Majid Rasool Kamli. 2019. Protein Modificomics. Protein Modificomics 203 227 .
Samir Zakhari & Jan Hoek. (2018) Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?. Cancers 10:10, pages 349.
Crossref
Deepa Rajagopalan & Sudhakar Jha. (2018) An epi(c)genetic war: Pathogens, cancer and human genome. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1869:2, pages 333-345.
Crossref
Shivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, Bing Yang, Cedric Shi, Glenn O. Allen, Wei Huang, John Denu & David Jarrard. (2017) Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes. BMC Cancer 17:1.
Crossref
Sujeenthar Tharmalingam, Shayenthiran Sreetharan, Adomas V. Kulesza, Douglas R. Boreham & T. C. Tai. (2017) Low-Dose Ionizing Radiation Exposure, Oxidative Stress and Epigenetic Programing of Health and Disease. Radiation Research 188:4.2, pages 525-538.
Crossref
Somnath PandeyKevin Pruitt. (2017) Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate. Biochemistry and Cell Biology 95:3, pages 368-378.
Crossref
Jos? Ignacio Mart?n-Subero & Manel Esteller. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer 263 275 .
David M. Nelson, Farah Jaber-Hijazi, John J. Cole, Neil A. Robertson, Jeffrey S. Pawlikowski, Kevin T. Norris, Steven W. Criscione, Nikolay A. Pchelintsev, Desiree Piscitello, Nicholas Stong, Taranjit Singh Rai, Tony McBryan, Gabriel L. Otte, Colin Nixon, William Clark, Harold Riethman, Hong Wu, Gunnar Schotta, Benjamin A. Garcia, Nicola Neretti, Duncan M. Baird, Shelley L. Berger & Peter D. Adams. (2016) Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biology 17:1.
Crossref
. (2016) Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues. Oncoscience, pages 751.
Crossref
G. Deblois & M. Lupien. 2016. Medical Epigenetics. Medical Epigenetics 351 374 .
Roberta Noberini, Alessandro Cuomo & Tiziana Bonaldi. 2016. Epigenetic Biomarkers and Diagnostics. Epigenetic Biomarkers and Diagnostics 195 214 .
Niraj Kumar Jha, Saurabh Kumar Jha, Satyaprakash, Rohan Kar, Deepak Rathore, Rashmi K. Ambasta & Pravir Kumar. 2016. Epigenetic Advancements in Cancer. Epigenetic Advancements in Cancer 145 176 .
Syed A. Mian, Kevin Rouault-Pierre, Alexander E. Smith, Thomas Seidl, Irene Pizzitola, Aytug Kizilors, Austin G. Kulasekararaj, Dominique Bonnet & Ghulam J. Mufti. (2015) SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment. Nature Communications 6:1.
Crossref
Eric Hervouet, Aurore Claude-Taupin, Thierry Gauthier, Valérie Perez, Annick Fraichard, Pascale Adami, Gilles Despouy, Franck Monnien, Marie-Paule Algros, Michèle Jouvenot, Régis Delage-Mourroux & Michaël Boyer-Guittaut. (2015) The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models. BMC Cancer 15:1.
Crossref
Scott H. Deibel, Erin L. Zelinski, Robin J. Keeley, Olga Kovalchuk & Robert J. McDonald. (2015) Epigenetic alterations in the suprachiasmatic nucleus and hippocampus contribute to age-related cognitive decline. Oncotarget 6:27, pages 23181-23203.
Crossref
Yoshimi Shinchi, Miki Hieda, Yu Nishioka, Ayaka Matsumoto, Yuhki Yokoyama, Hiroshi Kimura, Shuji Matsuura & Nariaki Matsuura. (2015) SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3. Experimental Cell Research 334:1, pages 90-99.
Crossref
Lidia Luzhna, Yaroslav Ilnytskyy & Olga Kovalchuk. (2015) Mobilization of LINE-1 in irradiated mammary gland tissue may potentially contribute to low dose radiation-induced genomic instability. Genes & Cancer 6:1-2, pages 71-81.
Crossref
José Ignacio Martín-Subero & Manel Esteller. 2015. Systems Biology of Cancer. Systems Biology of Cancer 113 133 .
. 2015. Systems Biology of Cancer. Systems Biology of Cancer 93 168 .
Shafqat Ali Khan. (2015) Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?. World Journal of Biological Chemistry 6:4, pages 333.
Crossref
Caroline Ospelt & Steffen Gay. 2015. Rheumatology. Rheumatology 139 144 .
Stefan Kruger, Zakaria Y Abd Elmageed, David H Hawke, Philipp M Wörner, David A Jansen, Asim B Abdel-Mageed, Eckhard U Alt & Reza Izadpanah. (2014) Molecular characterization of exosome-like vesicles from breast cancer cells. BMC Cancer 14:1.
Crossref
Grace Chappell, Tetyana Kobets, Bridget O’Brien, Natalia Tretyakova, Dewakar Sangaraju, Oksana Kosyk, Kenneth G. Sexton, Wanda Bodnar, Igor P. Pogribny & Ivan Rusyn. (2014) Epigenetic Events Determine Tissue-Specific Toxicity of Inhalational Exposure to the Genotoxic Chemical 1,3-Butadiene in Male C57BL/6J Mice. Toxicological Sciences 142:2, pages 375-384.
Crossref
Linda Zane, Vivek Sharma & Tom Misteli. (2014) Common features of chromatin in aging and cancer: cause or coincidence?. Trends in Cell Biology 24:11, pages 686-694.
Crossref
Manuraj Pandey, Satya Sahay, Prakash Tiwari, Daya S. Upadhyay, Sarwat Sultana & Krishna P. Gupta. (2014) Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: Potential targets for cancer control. Toxicology and Applied Pharmacology 280:2, pages 296-304.
Crossref
Yuhki Yokoyama, Ayaka Matsumoto, Miki Hieda, Yoshimi Shinchi, Eri Ogihara, Mai Hamada, Yu Nishioka, Hiroshi Kimura, Katsuhide Yoshidome, Masahiko Tsujimoto & Nariaki Matsuura. (2014) Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity. Breast Cancer Research 16:3.
Crossref
Anna Wojcicka, Agnieszka Piekielko–Witkowska, Hanna Kedzierska, Beata Rybicka, Piotr Poplawski, Joanna Boguslawska, Adam Master & Alicja Nauman. (2014) Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer. PLoS ONE 9:5, pages e97624.
Crossref
Stacey M. Southall, Nora B. Cronin & Jon R. Wilson. (2014) A novel route to product specificity in the Suv4-20 family of histone H4K20 methyltransferases. Nucleic Acids Research 42:1, pages 661-671.
Crossref
Masao Izawa, Fuminori Taniguchi & Tasuku Harada. 2014. Endometriosis. Endometriosis 107 123 .
Richard Chesworth, Tim J. Wigle, Kevin W. Kuntz, Jesse J. Smith & Victoria M. Richon. 2014. Epigenetic Therapy of Cancer. Epigenetic Therapy of Cancer 189 226 .
Olga Kovalchuk. (2013) Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells. International Journal of Oncology.
Crossref
Caroline Ospelt & Steffen Gay. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 316 324 .
Moray J. Campbell & Bryan M. Turner. 2013. Epigenetic Alterations in Oncogenesis. Epigenetic Alterations in Oncogenesis 81 107 .
Turang E Behbahani, Philip Kahl, Johannes von der Gathen, Lukas C Heukamp, Claudia Baumann, Ines Gütgemann, Bernhard Walter, Ferdinand Hofstädter, Patrick J Bastian, Alexander von Ruecker, Stefan C Müller, Sebastian Rogenhofer & Jörg Ellinger. (2012) Alterations of global histone H4K20 methylation during prostate carcinogenesis. BMC Urology 12:1.
Crossref
Bekim Sadikovic & David I. Rodenhiser. 2012. Toxicology and Epigenetics. Toxicology and Epigenetics 111 127 .
F.O. Andrade, M.K. Nagamine, A. De Conti, L.M. Chaible, C.C. Fontelles, A.A. Jordão Junior, H. Vannucchi, M.L.Z. Dagli, B.K. Bassoli, F.S. Moreno & T.P. Ong. (2012) Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells. Brazilian Journal of Medical and Biological Research 45:9, pages 841-850.
Crossref
Igor KoturbashNatalie E. SimpsonFrederick A. BelandIgor P. Pogribny. (2012) Alterations in Histone H4 Lysine 20 Methylation: Implications for Cancer Detection and Prevention. Antioxidants & Redox Signaling 17:2, pages 365-374.
Crossref
Natalie E. Simpson, Volodymyr P. Tryndyak, Frederick A. Beland & Igor P. Pogribny. (2011) An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Research and Treatment 133:3, pages 959-968.
Crossref
Juan Sandoval & Manel Esteller. (2012) Cancer epigenomics: beyond genomics. Current Opinion in Genetics & Development 22:1, pages 50-55.
Crossref
Moon Kyung Choe, Chang-Pyo Hong, Jihwan Park, Seong Hye Seo & Tae-Young Roh. (2012) Functional elements demarcated by histone modifications in breast cancer cells. Biochemical and Biophysical Research Communications 418:3, pages 475-482.
Crossref
Masoud Ghorbani, Turaya Naas, Catalina Soare, Rashmi Kothary & Francisco Diaz-Mitoma. (2012) Microarray analysis of gene expression in the liver of transgenic mouse model of HCV infection. Advances in Bioscience and Biotechnology 03:08, pages 1151-1159.
Crossref
Antje Stratmann & Bernard Haendler. (2012) Histone demethylation and steroid receptor function in cancer. Molecular and Cellular Endocrinology 348:1, pages 12-20.
Crossref
Slava Ilnytskyy, Jody Filkowski & Olga Kovalchuk. 2012. Radiobiology and Environmental Security. Radiobiology and Environmental Security 53 66 .
Yu-Ching Fang, Po-Ting Lai, Hong-Jie Dai & Wen-Lian Hsu. (2011) MeInfoText 2.0: gene methylation and cancer relation extraction from biomedical literature. BMC Bioinformatics 12:1.
Crossref
Rosa M. Marión, Gunnar Schotta, Sagrario Ortega & Maria A. Blasco. (2011) Suv4-20h Abrogation Enhances Telomere Elongation during Reprogramming and Confers a Higher Tumorigenic Potential to iPS Cells. PLoS ONE 6:10, pages e25680.
Crossref
Ann-Christin Schneider, Lukas C. Heukamp, Sebastian Rogenhofer, Guido Fechner, Patrick J. Bastian, Alexander von Ruecker, Stefan C. Müller & Jörg Ellinger. (2011) Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer. BJU International 108:8b, pages E290-E296.
Crossref
Yaroslav Ilnytskyy & Olga Kovalchuk. (2011) Non-targeted radiation effects—An epigenetic connection. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 714:1-2, pages 113-125.
Crossref
J Füllgrabe, E Kavanagh & B Joseph. (2011) Histone onco-modifications. Oncogene 30:31, pages 3391-3403.
Crossref
Alessandro Cuomo, Simona Moretti, Saverio Minucci & Tiziana Bonaldi. (2010) SILAC-based proteomic analysis to dissect the “histone modification signature” of human breast cancer cells. Amino Acids 41:2, pages 387-399.
Crossref
Maria Hatziapostolou & Dimitrios Iliopoulos. (2011) Epigenetic aberrations during oncogenesis. Cellular and Molecular Life Sciences 68:10, pages 1681-1702.
Crossref
Amaia Lujambio & Manel Esteller. 2012. Cancer Metastasis. Cancer Metastasis 85 95 .
Hsing-Chen Tsai & Stephen B Baylin. (2011) Cancer epigenetics: linking basic biology to clinical medicine. Cell Research 21:3, pages 502-517.
Crossref
Hiroshi Hashizume, Urara Gomita, Masayoshi Imagawa & Shigehiro Osada. (2011) Histone Methyltransferase PR-Set7 and Histone Variant H2A.Z, Induced during Hepatocarcinogenesis, Repress the Promoter Activity of the Tumor Marker Gene and the Ras-Induced Colony Formation Activity. Journal of Health Science 57:3, pages 264-273.
Crossref
A. L. Turinsky, B. Turner, R. C. Borja, J. A. Gleeson, M. Heath, S. Pu, T. Switzer, D. Dong, Y. Gong, T. On, X. Xiong, A. Emili, J. Greenblatt, J. Parkinson, Z. Zhang & S. J. Wodak. (2010) DAnCER: Disease-Annotated Chromatin Epigenetics Resource. Nucleic Acids Research 39:Database, pages D889-D894.
Crossref
Santiago Uribe-Lewis, Kathryn Woodfine, Lovorka Stojic & Adele Murrell. (2011) Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Reviews in Molecular Medicine 13.
Crossref
Esteban Ballestar. 2011. Epigenetic Contributions in Autoimmune Disease. Epigenetic Contributions in Autoimmune Disease 1 11 .
Leanna W. K. Tsang, Ninghe Hu & D. Alan Underhill. (2010) Comparative Analyses of SUV420H1 Isoforms and SUV420H2 Reveal Differences in Their Cellular Localization and Effects on Myogenic Differentiation. PLoS ONE 5:12, pages e14447.
Crossref
Igor P. Pogribny, Jody N. Filkowski, Volodymyr P. Tryndyak, Andrey Golubov, Svitlana I. Shpyleva & Olga Kovalchuk. (2010) Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin. International Journal of Cancer 127:8, pages 1785-1794.
Crossref
Tina Bianco-Miotto, Karen Chiam, Grant Buchanan, Shalini Jindal, Tanya K. Day, Mervyn Thomas, Marie A. Pickering, Melissa A. O'Loughlin, Natalie K. Ryan, Wendy A. Raymond, Lisa G. Horvath, James G. Kench, Phillip D. Stricker, Villis R. Marshall, Robert L. Sutherland, Susan M. Henshall, William L. Gerald, Howard I. Scher, Gail P. Risbridger, Judith A. Clements, Lisa M. Butler, Wayne D. Tilley, David J. Horsfall & Carmela Ricciardelli. (2010) Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development. Cancer Epidemiology, Biomarkers & Prevention 19:10, pages 2611-2622.
Crossref
Susana Gonzalo. (2010) Epigenetic alterations in aging. Journal of Applied Physiology 109:2, pages 586-597.
Crossref
Matthias Hahn, Silvia Dambacher & Gunnar Schotta. (2010) Heterochromatin dysregulation in human diseases. Journal of Applied Physiology 109:1, pages 232-242.
Crossref
Melanie Ehrlich. (2009) DNA hypomethylation in cancer cells. Epigenomics 1:2, pages 239-259.
Crossref
Vincenzo Calvanese, Ester Lara, Arnold Kahn & Mario F. Fraga. (2009) The role of epigenetics in aging and age-related diseases. Ageing Research Reviews 8:4, pages 268-276.
Crossref
Andreas Lennartsson & Karl Ekwall. (2009) Histone modification patterns and epigenetic codes. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:9, pages 863-868.
Crossref
Stefan Schoeftner & Maria A Blasco. (2009) A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs. The EMBO Journal 28:16, pages 2323-2336.
Crossref
Somaia E. Elsheikh, Andrew R. Green, Emad A. Rakha, Des G. Powe, Rabab A. Ahmed, Hilary M. Collins, Daniele Soria, Jonathan M. Garibaldi, Claire E. Paish, Amr A. Ammar, Matthew J. Grainge, Graham R. Ball, Magdy K. Abdelghany, Luisa Martinez-Pomares, David M. Heery & Ian O. Ellis. (2009) Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome. Cancer Research 69:9, pages 3802-3809.
Crossref
Hongbo YangCraig A. Mizzen. (2009) The multiple facets of histone H4-lysine 20 methylationThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.. Biochemistry and Cell Biology 87:1, pages 151-161.
Crossref
Gaetano Gargiulo & Saverio Minucci. (2009) Epigenomic profiling of cancer cells. The International Journal of Biochemistry & Cell Biology 41:1, pages 127-135.
Crossref
Esteban Ballestar & Manel Esteller. 2009. Epigenomics. Epigenomics 369 384 .
Arnaud Van Den Broeck, Elisabeth Brambilla, Denis Moro-Sibilot, Sylvie Lantuejoul, Christian Brambilla, Beatrice Eymin, Saadi Khochbin & Sylvie Gazzeri. (2008) Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer. Clinical Cancer Research 14:22, pages 7237-7245.
Crossref
Deepak Kumar & Mukesh Verma. 2008. Cancer Epigenetics. Cancer Epigenetics 347 357 .
Melanie Ehrlich. 2008. Cancer Epigenetics. Cancer Epigenetics 235 252 .
Hongbo Yang, James J. Pesavento, Taylor W. Starnes, Diane E. Cryderman, Lori L. Wallrath, Neil L. Kelleher & Craig A. Mizzen. (2008) Preferential Dimethylation of Histone H4 Lysine 20 by Suv4-20. Journal of Biological Chemistry 283:18, pages 12085-12092.
Crossref
Manel Esteller. (2008) Epigenetics in Cancer. New England Journal of Medicine 358:11, pages 1148-1159.
Crossref
Amaia Lujambio & Manel Esteller*. 2008. Current Perspectives in microRNAs (miRNA). Current Perspectives in microRNAs (miRNA) 367 384 .
Mario F. Fraga & Manel Esteller. (2007) Epigenetics and aging: the targets and the marks. Trends in Genetics 23:8, pages 413-418.
Crossref
Paul S. Knoepfler. (2007) Myc Goes Global: New Tricks for an Old Oncogene. Cancer Research 67:11, pages 5061-5063.
Crossref
M. F. FRAGA, R. AGRELO & M. ESTELLER. (2007) Cross-Talk between Aging and Cancer: The Epigenetic Language. Annals of the New York Academy of Sciences 1100:1, pages 60-74.
Crossref
Manel Esteller. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Reviews Genetics 8:4, pages 286-298.
Crossref
Vasyl' F. Chekhun, Nataliya Yu Lukyanova, Olga Kovalchuk, Volodymyr P. Tryndyak & Igor P. Pogribny. (2007) Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Molecular Cancer Therapeutics 6:3, pages 1089-1098.
Crossref
David S. Schrump, Julie A. Hong & Dao M. Nguyen. (2007) Utilization of Chromatin Remodeling Agents for Lung Cancer Therapy. The Cancer Journal 13:1, pages 56-64.
Crossref
Ann S. Wilson, Barbara E. Power & Peter L. Molloy. (2007) DNA hypomethylation and human diseases. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1775:1, pages 138-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.